Genscript Biotech Corporation
Genscript Biotech Corporation (GNNSF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GNNSF · as of Jun 9, 2026
Key Statistics
Explore Genscript Biotech Corporation Data
gnnsf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
gnnsf competitorsGNNSF
AKBLF
CAMRF
CZMWF
INCPF
LABFFStock Performance
Full HistoryAbout Genscript Biotech Corporation
Genscript Biotech Corporation an investment holding firm, operates on a global scale as a leading provider of life science research products and services, serving North America, Europe, China, Japan,…
what is genscript biotech corporation · gnnsf stock overview · genscript biotech corporation company profile · who is genscript biotech corporation ceo · gnnsf OTC · genscript biotech corporation headquarters · genscript biotech corporation business segments
About Stock Overview & Key Data
Genscript Biotech Corporation (GNNSF) is a Healthcare company in the Biotechnology industry, listed on OTC since Sep 28, 2017. As of the latest trading session, GNNSF stock price is $1.90, with a market capitalization of $4.2B. The stock has returned -7.32% over the past 12 months and +14.46% year-to-date.
In fiscal year 2025, Genscript Biotech Corporation reported revenue of $960.9M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Genscript Biotech Corporation (GNNSF) stock price is $1.90. The stock is traded on OTC under the ticker symbol GNNSF. The 52-week range is $1.30 – $2.42.